Related Experiment Videos
Bone loss and bone turnover in diabetes
J C Krakauer1, M J McKenna, N F Buderer
1Division of Bone and Mineral Metabolism, Henry Ford Hospital, Detroit, Michigan 48202, USA.
Diabetes
|July 1, 1995
Summary
Diabetes impacts bone density differently based on type. While type I diabetes shows continued bone loss, type II diabetes patients experienced bone density improvement over time, correcting initial deficits.
Area of Science:
- Endocrinology
- Bone Metabolism
- Diabetes Research
Background:
- Conflicting reports exist regarding diabetes' effect on bone density.
- Previous studies have not fully elucidated the long-term bone density changes in diabetic patients.
Purpose of the Study:
- To investigate the longitudinal changes in bone density in patients with type I and type II diabetes.
- To compare bone density and bone formation rates between diabetic patients and non-diabetic controls.
Main Methods:
- Longitudinal study of 109 patients (46 type I, 63 type II diabetes) with initial measurements in 1978 and follow-ups.
- Bone density measurements (radial) and bone biopsies for histological assessment of bone formation were performed.
- Patients were restudied approximately 2.5 and 12.5 years after baseline.
Main Results:
- Initially, diabetic patients had significantly lower radial bone density than controls.
- Bone formation rates were markedly depressed in osteopenic diabetic patients.
- Type I diabetes showed continued bone loss, maintaining the initial deficit.
- Type II diabetes patients exhibited slower bone loss, completely correcting the initial deficit over time.
- Several type II diabetes patients showed improved bone mineral density z-scores, even exceeding normal ranges.
Conclusions:
- Diabetes influences bone density through multiple mechanisms including impaired bone formation and altered resorption.
- Type I diabetes is associated with persistent bone loss, while type II diabetes may lead to improved bone density over the long term.
- Low bone turnover in diabetes may retard age-related bone loss, with potential for bone density normalization or increase in type II diabetes.